GovChime
Notice ID: c555198cd29c4512b1a1559d758c734bAward NoticeAwardedArchived

NINDS BPN Preclinical Testing and Toxicology Program

Awarded on September 12, 2026. Full description on SAM.gov.

Awarded tounder HHSN271201600006I (source: SAM.gov award notice)• $0

Overview

Posted
September 17, 2026
Notice type
Award Notice
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NATIONAL INSTITUTES OF HEALTH OLAO
Last updated
Oct 28, 2026
First published
Last updated on SAM.gov
Award date
Sep 12, 2026
Award amount (SAM.gov award notice)
$0

Identifiers

Solicitation number
A75N98026R00138
Notice ID
c555198cd29c4512b1a1559d758c734b
Award number (PIID)
HHSN271201600006I

Description

NINDS Blueprint Neurotherapeutics Network (BPN) extended the ordering period of four (4) existing Indefinite Delivery, Indefinite Quantity (IDIQ) contracts awarded under the BPN Preclinical Testing and Toxicology Program (PTTP), with the contractors listed below. This action extends the ordering period by one year, from September 13, 2026, through September 12, 2027. This is a no-cost modification; no other changes to the contracts' terms, conditions, scope, or ceiling value are being made.

SRI International      

HHSN271201600006I

Southern Research 

HHSN271201600007I            

IIT Research Institute (IITRI)

75N95021D00026

University of Illinois Chicago, Toxicology Research Laboratory (TRL)             

75N95022D00026

Please refer to the attached justification for additional information.

Full description on SAM.gov

Award Overview

Award Number

HHSN271201600006I

Award Amount (SAM.gov award notice)

$0

Award Date

Sep 12, 2026

Awardee

Awardee UEI

M28UHK4YUC87

Awardee CAGE Code

2D341

Awardee Address

Arlington, VA 22209, UNITED STATES

Original Solicitation

Notice ID: c555198cd29c4512b1a1559d758c734b

Posted Date: Sep 17, 2026

Original Response Deadline: Not specified

Task Orders Under This IDV

Top 10 by total obligated

10
  • HHSN27100003
    SRI INTERNATIONAL
    Department of Health and Human ServicesNAICS 541711
    $2.9MSigned Sep 9, 2026
  • HHSN27100003
    SRI INTERNATIONAL
    Department of Health and Human ServicesNAICS 541711
    $2.9MSigned Jan 4, 2022
  • 75N95022F00001
    SRI INTERNATIONAL
    Department of Health and Human ServicesNAICS 541711
    $2.7MSigned Mar 11, 2024
  • HHSN27100003
    SRI INTERNATIONAL
    Department of Health and Human ServicesNAICS 541711
    $2.7MSigned Jul 20, 2021
  • HHSN27100003
    SRI INTERNATIONAL
    Department of Health and Human ServicesNAICS 541711
    $2.7MSigned May 18, 2021
  • 75N95019F00092
    SRI INTERNATIONAL
    Department of Health and Human ServicesNAICS 541711
    $2.5MSigned Aug 17, 2023
  • 75N95022F00001
    SRI INTERNATIONAL
    Department of Health and Human ServicesNAICS 541711
    $2.5MSigned Sep 16, 2024
  • 75N95019F00092
    SRI INTERNATIONAL
    Department of Health and Human ServicesNAICS 541711
    $2.5MSigned Sep 17, 2025
  • 75N95020F00001
    SRI INTERNATIONAL
    Department of Health and Human ServicesNAICS 541711
    $2.4MSigned Feb 23, 2022
  • 75N95020F00001
    SRI INTERNATIONAL
    Department of Health and Human ServicesNAICS 541711
    $2.4MSigned Jun 10, 2021

More From This Vendor

Top 5 most recent

5
  • HHSO100201600007C
    SRI INTERNATIONAL
    Department of Health and Human ServicesNAICS 541711
    $19.4MSigned Sep 28, 2026
  • 75N95019F00092
    SRI INTERNATIONAL
    Department of Health and Human ServicesNAICS 541711
    $2.2MSigned Sep 18, 2026
  • HHSO100201500032C
    SRI INTERNATIONAL
    Department of Health and Human ServicesNAICS 541711
    $3.8MSigned Sep 15, 2026
  • 75N93019F00131
    SRI INTERNATIONAL
    Department of Health and Human ServicesNAICS 541711
    $9.3MSigned Sep 14, 2026
  • HHSN27100003
    SRI INTERNATIONAL
    Department of Health and Human ServicesNAICS 541711
    $2.9MSigned Sep 9, 2026

Contacts

Contracting Officer

Primary Contact

Documents

Files (1)

  • NINDS PTTP IDIQ Ext._JOFOC_Final for Approval_oamp_redacted_Redacted.pdf

    1.8 MBAdded in Award Notice version 3Posted
    Download

Lifecycle

  1. 3
    Version 3Award NoticeArchivedCurrent

    NINDS BPN Preclinical Testing and Toxicology Program

    Notice c555198cd29c4512b1a1559d758c734b on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
This Presolicitation notice is NOT a Request for Quotation (RFQ)/Solicitation, however all responsible sources may submit a capability statement, quotation, bid, or proposal, as appropriate, which will be considered by the agency. The Government intends to award a purchase order to Information Management Services on a sole source basis under the authority of RFO FAR 12.102(a) - Restricting competition. Responses shall be submitted electronically to Jacob Balenson via email to jacob.balenson@nih.gov, and Sandra Daniels sandra.daniels@nih.gov no later than November 25, 2026 at 10:00 AM (Eastern Time). Emails must reference Presolicitation Number 75N98027Q00046 in the subject line. See attached Presolicitation Notice and Statement of Work (SOW) for more information.
-Pre-Solicitation11/25/2026
Synopsis: This is a Small Business Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding: (1) the availability and capability of qualified small business sources to perform a potential requirement; (2) whether they are small businesses; 8(a) small businesses, service-disabled veteran-owned small businesses; veteran-owned small businesses; women-owned small businesses; HUBZone small businesses; or small disadvantaged businesses; and (3) their size classification relative to the North American Industry Classification system (NAICS) code for the potential acquisition. Your responses to the information requested will assist the government in determining the appropriate acquisition method, including whether a small business set aside is possible. An organization that is not considered a small business under the applicable NAICS code should not submit a response to this notice. The requirement is assigned a code of 541715 in the North American Industry Classification System (NAICS), and the small business size standard for such requirements is 1,000 employees or less. This notice is issued for market research purposes to assess potential small business sources, industry practices, and the availability of commercial services. The Government has not made a final determination regarding acquisition strategy, contract type, commerciality, or small business set-aside status. Respondents should identify whether they can perform the requirement as a prime contractor, including through existing teaming arrangements or qualified subcontractors, and distinguish their own capabilities from those of proposed team members. Background: The National Institute on Minority Health and Health Disparities (NIMHD) conducts and supports research and training programs to advance knowledge and understanding of health disparities, identify mechanisms to improve minority health and reduce health disparities, and develop effective interventions in community and clinical settings. NIMHD is the lead organization at the National Institutes of Health (NIH) for planning, reviewing, coordinating, and evaluating minority health and health disparities research activities. NIMHD also promotes workforce development, supports research capacity at less-resourced institutions that train students in research careers, serves populations experiencing health disparities, supports participation in clinical research, and promotes information dissemination through regular communications, public education outreach, and scientific presentations. The President’s Executive Order (EO) 14212 Establishing the President’s Make America Healthy Again Commission aims to improve the health of Americans. As described in the EO, escalating burden of chronic diseases poses significant challenges in the United States. These conditions contribute to rising health costs, reduced workforce productivity, and stagnant life expectancies across the country, both in adults and children. NIH defines a health disparity as a measurable difference in health that exists between specific population groups. This is a rigorously derived and data-driven determination operationalized by quantifiable metrics, rather than a statement of attribution. It is a scientific starting point that identifies where health outcomes diverge, not a predetermined conclusion about why. Scientific investigations to identify or understand the root causes are separate and distinct scientific questions, which are necessarily multifaceted and complex. NIH funded research is interested in those health disparities that are modifiable or actionable to improve the health of all population groups. Health disparities may be observed in the risks, prevalence, or problems resulting from specific behaviors, as well as the incidence, prevalence, and mortality from conditions, diseases, and/or disorders. To fulfill the NIH mission of seeking fundamental knowledge about the nature and behaviors of individuals as living systems, and the statutory purpose of NIMHD, to conduct research to understand and reduce health disparities, NIMHD Division of Intramural Research (DIR) conducts population health research to understand how health outcomes vary across populations, identify multilevel modifiable factors that drive these disparities, and develop, test, and evaluate clinical and population-based interventions to reduce these disparities. NIMHD DIR requires contractor assistance to provide R&D social and behavioral sciences research services to support NIMHD DIR in conducting population health and clinical research to understand and reduce health disparities in the United States. The Government anticipates that individual task orders may involve differing research designs, study populations, sites, durations, and levels of complexity. Interested firms should explain their ability to mobilize qualified personnel and research resources for multiple concurrent studies as requirements arise. NIMHD is seeking small businesses capable of designing, conducting and overseeing the clinical, scientific, and technical aspects of investigations into health disparities across populations, to identify modifiable risk and protective factors associated with these disparities, and develop and test interventions to reduce these disparities. Study designs to be used may include, but are not limited to: Population-based cross-sectional surveys; Epidemiological studies (e.g., longitudinal cohort study, case-control studies); Clinical trials; Community-based intervention studies; Simulation modeling; and Qualitative research methods (e.g., direct observations, in-depth interviews, focus groups discussions). Independently and not as an agent of the Government, the Contractor shall furnish all necessary services, qualified personnel, material, equipment, and facilities not otherwise provided by the Government to successfully perform the requirements stated below. Specifically, the Contractor shall, as required by individual task orders, perform the following technical requirements summarized below that also are included in the attached Draft Statement of Work (SOW), including but not limited to: Provide personnel, facilities, and other services necessary to maintain and coordinate multiple health disparities research studies funded through task orders under this Indefinite Delivery, Indefinite Quantity (IDIQ) contract. Provide overall project management and coordination of activities performed under individual task orders, including development and maintenance of project plans, schedules, milestones, coordination of participating research sites and subcontractors, monitoring of performance, identification and resolution of project risks and issues, and preparation of progress reports as specified in the applicable task order. Conduct research studies through qualified organizations, as specified in individual task orders, and receiving consent from the Contracting Officer’s Representative (COR) and Contracting Officer (CO). This includes (but is not limited to) implementation of protocols; population health and clinical research site monitoring; regulatory compliance assurance; and analyses of data from clinical, laboratory, population and epidemiologic studies. Provide and manage participating population health research and clinical trial sites, investigators, laboratories, and other research resources necessary to conduct studies, directly or through qualified subcontractors. The Contractor shall draft, negotiate, execute, administer, monitor, renew and/or modify as necessary, subject to subcontractor's satisfactory past performance, and with the consent of the CO, subcontracts with domestic population health studies, clinical research sites and laboratories, and provide support for these population health studies, clinical research site and laboratories. The Contractor shall assume responsibility for population health and clinical sites, including site readiness to start new research studies. This includes the establishment of new subcontract agreements for these sites (including laboratories), data management, and other operations and functions. As existing protocols close, the Contractor shall assume responsibility for any new protocols at these sites. Recruit and retain numbers of potential research subjects sufficient for the timely completion of all protocols. Provide United States based investigators in the United States with expertise in the population health and clinical care, to conduct protocols specified through individual task orders. Provide professional and technical staff adequate to provide scientific and administrative coordination of multiple population health and clinical health disparities research studies. These staff shall include, but are not limited to, qualified medical, nursing, and neuropsychologic staff, study coordinators, personnel for participant identification, recruitment, study conduct, and retention, pharmacists, and laboratory technicians. Ensure sites have access to populations of interest, laboratory facilities with the capability to perform clinical research specified in task orders. Identify and engage community organizations, community leaders, health care providers, and other relevant stakeholders; establish and support community advisory boards, community coalitions, or other partnerships; conduct community needs and readiness assessments; and facilitate community participation in research planning, implementation, and dissemination of findings. Develop and implement quantitative and qualitative data collection methods, including surveys, interviews, focus groups, direct observations, and other methods appropriate to the research protocol. The Contractor shall manage, analyze, and report data collected through these methods, as required by individual task orders. Provide facilities and equipment adequate to conduct population health, inpatient and outpatient clinical research studies. Equipment purchases must be approved by the COR and CO. Ensure that sites have (through lease or direct provision, if required) electronic information systems compliant with the Federal Information Security Modernization Act (FISMA), necessary specialized equipment (including hardware and software) for sites to electronically communicate with the Contractor, subcontractors, and NIMHD DIR as required, for processing and storage of biospecimens (e.g., ultralow temperature freezer, specialized shipping materials and training for shipment of biohazardous materials and dangerous goods, and for receipt, storage, monitoring, and dispensing of investigational drugs). Obtain access for research protocol review and approval (or exemption) to a standing Institutional Review Board (IRB) and ensure that each institution conducting population health and clinical research studies has a current, approved Federal-Wide Assurance Number on file with the Office for Human Research Protections (OHRP). Ensure that all the staff at each site participating in the design or conduct of population health and clinical research involving human subjects, complete and maintain education on the human research protections. Ensure that when appropriate, population health and clinical research sites have a community advisory board (CAB) constituted with members of the local community that can provide community perspective and advice for science in the community where the population health and clinical research is located and that provides community input. The Contractor shall provide services to ensure regulatory compliance for research activities including subcontracted sites' performance. More specifically: Ensure site access to a communications system in compliance with U.S. Food and Drug Administration (FDA) requirements for the submission of Adverse Experience Reports (AERs) by Subcontractors to the Contractor for transmission as required to the COR as required. Monitor the accuracy of adverse experience reporting through regular summary reports for submission to the COR. Draft safety reports as required by the FDA for selected studies for COR Submission. Develop, implement, and monitor plans for acquisition, distribution, dispensing, handling, administration, and accountability of study interventions (pharmaceutical and non-pharmaceutical), in compliance with applicable Federal, state, and local regulations. Provide site monitoring for quality assurance of research conducted at all clinical and laboratory sites, as designated by the COR. Monitoring schedules shall be approved by and results reported to the COR with a copy to the CO and shall include assurance of compliance with FDA record keeping and reporting requirements (21 CFR 50 and 56; 21 CFR 312.50, Subpart D), accuracy and completeness of case report forms, source documentation, and other research records, and periodic record auditing and documentation by the staff of the subcontracted centers. Each site shall be visited a minimum of 2-3 times annually. Provide staff with laboratory expertise and assist in monitoring clinical trials site laboratory quality with the COR and NIMHD Quality Assurance (QA) programs. Meet with the NIMHD program and contracting staff to review annual site performance and monitoring reports for participating population health and clinical research sites. The Contractor shall provide population health, clinical and statistical analysis and reports. More specifically: Provide scientific, technical, and administrative support for the development, implementation, and analysis of the specified research, including considerations of experimental design, sample size calculation, and interim and final primary and secondary analyses specified by study protocols, as requested by the COR. Establish data elements to be recorded by the protocol research records, as requested by the COR and in conjunction with the protocol development team for each specific research project. Develop study forms for standardized collection of data items. Develop documentation and coding for computerization of data for retrieval, analysis, and reporting. Provide for timely and accurate data collection and submission, data entry, data quality assurance, retrieval of source documentation, and generation of data and safety monitoring reports. Provide training for staff of population health, clinical and laboratory sites in data management procedures. Provide data input, editing, electronic data storage, database management, data retrieval, and statistical analysis using well-documented database management and statistical computer software programs. Develop methodology, perform analyses, and provide results from meta-analyses of selected data sets derived from population health and clinical research studies that focus on health disparities. Provide data analysis and results. More specifically: Perform statistical analyses of study data to test study hypotheses and evaluate potential confounding variables and/or covariates, as requested by the COR. Data analytic techniques needed include approaches to analyzing multiple measurements of biologic variables over time within participants and between participant groups, with consideration for normal changes in these variables with demographics. Provide for biweekly to monthly communication, as needed, of analytic progress and results through routine meetings (the majority to be virtually) with COR or designees and periodic generation of reports. The Project Manager shall attend all meetings. The Epidemiologist, Statistician, and Senior Systems Analyst shall attend these meetings on an as needed basis dependent upon the PI’s request. Provide programming and statistical support adequate for the timely generation of additional analyses requested by the COR. Provide electronic data transmission between the Contractor, population health, clinical and laboratory sites, and NIMHD DIR using currently specified communications software and equipment. Provide for electronic mail transmission between the Contractor, population health, clinical and laboratory sites, and NIMHD DIR using commercially available communications software and equipment. Provide protocol development services and assistance. The Contractor shall provide services for the implementation and monitoring of multiple population health and clinical research studies. More specifically: Develop, initiate and coordinate implementation and oversight of protocols at all participating population health, clinical and laboratory sites designed by the COR and approved by the CO. Ensure compliance by sites with all requirements for protocol implementation, including IRB review and approval prior to protocol initiation, participant consent, and confidentiality requirements, and Federal bioresearch regulations and requirements for security and confidentiality of research records, and that each relevant population health and clinical research site staff member completes and maintains human research protection and Good Clinical Practice training, when appropriate. Draft, negotiate, execute, administer, monitor, renew and/or modify as necessary with approval by CO a site-specific, protocol-specific budget for each protocol to be conducted by population health, clinical and laboratory sites, based on the anticipated number of participants to be enrolled. Provide training for staff of clinical and laboratory centers in procedures for implementation and conduct of specific protocols. Retraining may be required to be performed as necessary. Provide training in and ensure the fulfillment and maintenance of standards for Good Clinical Practices (GCP) and Good Clinical Laboratory Practices (GCLP) across population health and clinical research sites and staff, whenever appropriate. Ensure timely development and execution of material transfer agreements (MTAs) and data transfer agreements (DTAs) between the sponsor(s) and population health and clinical research sites. The Contractor shall provide services for the development and review of research activities. More specifically: For specific new protocol topics identified by the COR, identify a protocol development team consisting of Contractor staff, NIH staff, subcontractors, and/or consultants. Provide support for the planning and conduct of protocol development team meetings. Submit at the initial meeting a protocol development plan for COR review and approval, addressing regulatory issues, data collection forms development, drug distribution plan, protocol timeline, and participating sites. Develop a protocol document including background, objectives and endpoints, design, patient numbers, source, management, and selection, study agents or other interventions, clinical and laboratory monitoring, laboratory services, toxicity management, adverse experience reporting, evaluation of response, statistical considerations, data collection and monitoring, human subjects’ considerations, biohazard containment, and data and safety reviews. Review, edit, and rewrite draft protocols based on COR’s review. Prepare and maintain the necessary documentation for application submissions in compliance with FDA requirements. Upon completion of a final protocol, renegotiate subcontractor budgets with the approval of the CO and implement the new protocol at participating sites. For ongoing protocols, provide, at the request of the COR, support for the planning and conduct of meetings of protocol committees and subcommittees, data and safety monitoring boards, and investigators. Provide administrative, technical, and logistical support at the request of the COR and with approval of the CO as needed for interaction and collaboration of the Subcontractors with other institutes, agencies, and organizations conducting activities relevant to health disparities research. Support the identification, development, implementation, and evaluation of interventions to improve health outcomes and reduce health disparities, including assessment of feasibility, acceptability, effectiveness, and potential impact. Provide consultants with specialized expertise related to population health and clinical research especially related to health disparities, as requested by NIMHD DIR. Plan, organize, and coordinate meetings involving internal and outside experts. This meeting will be an important venue to discuss important and complex scientific issues related to research protocols and emerging research priorities. Provide support services for ongoing population health and clinical research studies, which include, but are not limited to, the following: site monitoring, subcontract management and invoicing, protocol management, oversight of data management and data analysis, study agent procurement, team meetings, regulatory compliance assurance, site activation and protocol registration, safety monitoring, committee management, data management services, oversight of central and site laboratories and pharmacies, protocol team support, FISMA compliance and IT security, laboratory equipment support, and training of site personnel, to support this effort. Provide Core infrastructure support for ongoing population health and clinical research at the sites, including but not limited to the following: maintenance of IRB/EC regulatory reporting, subject recruitment and follow-up, Community Advisory Board (CAB) support for meetings, protocol updates and reporting, attendance and participation in site monitoring visits, attendance at the annual network meeting, invoicing and other report preparation. Experience coordinating data from all aspects of ongoing protocols, studies, and trials. Experience in initiating and managing 3-6 studies each year. Experience initiating and managing studies of different sizes from approximately 100 participants up to approximately 10,000 participants. Experience working with populations experiencing health disparities, e.g., people in low socioeconomic conditions, living in rural underserved areas, and racial and/or ethnic populations who have documented health disparities based on diseases and conditions. Experience initiating and managing studies with a length in time from a few months for cross-sectional studies to a few years in clinical studies. Experience managing studies of varying complexities from simpler studies, which may be qualitative studies involving in-depth interviews with about 100 people; to more complex studies that involve a multi-site clinical trial with 1-2 years follow-up including biospecimen collection. Commercial Availability of Services – Based on preliminary market research, the Government anticipates that the contemplated research services may be noncommercial in nature. However, interested respondents are encouraged to identify comparable services available in the commercial marketplace. If so, describe which portions of the requirement could be met commercially and which would require customization, integration, or specialized development. Provide supporting information, including customary pricing practices and potential firm-fixed-price arrangements, if available. Industry Feedback on Draft SOW – Respondents are encouraged to provide comments or recommendations on the draft SOW, including opportunities to clarify requirements, improve performance outcomes, identify potential implementation challenges, or incorporate commercially available approaches. Identify any provisions that may unnecessarily limit small business participation and suggest practical alternatives. Any recommendations should identify the applicable SOW section when possible. Anticipated Award Date: The Government expects to award an Indefinite Delivery Indefinite Quantity (IDIQ) contract approximately in September 2027. Disclaimer and Important Notes: This notice does not obligate the government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization’s qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a presolicitation synopsis and solicitation may be published in SAM.gov. However, responses to this notice will not be considered adequate responses to a solicitation. No award will be made as a result of this notice. The Government will NOT be responsible for any costs incurred by the respondents to this Notice. This notice is for information purposes only. CONFIDENTIALITY: No proprietary, classified, confidential, or sensitive information should be included in your response. The government reserves the right to use any nonproprietary technical information in any resultant solicitation(s). Responses and Capability Statements: Interested Small Businesses that believe they possess the capabilities necessary to undertake this project should submit an electronic copy of their capability statement addressing the areas listed above to the attention of Edwin Osorio, Contract Specialist (E-mail: edwin.osorio@nih.gov) and Lisa Schaupp, Contracting Officer (E-mail: lisa.schaupp@nih.gov). Please state clearly in the subject line of the email that it is in response to the Sources Sought notice no.75N94027R00005. Please limit responses to 20 pages or less, exclusive of resumes. Electronic capability statements should be received by the Contracting Officer and Contract Specialist by 4:30 PM Eastern time on November 25, 2026. Respondents must submit their capability statement via electronic submission only. Capability statements must identify the 1) organization name, address, point of contact, contact phone number, and email address; 2) Small Business status of the organization, NAICS code along with SAM.gov Unique Entity Identifier (UEI) and CAGE code, if assigned, size and type of business (e.g., 8(a), HUBZone, etc.). No phone calls will be accepted. The designated NAICS code for this effort is 541715 and the size standard is 1,000 employees or less. Respondents may provide brief SOW comments and commercial availability information within the existing 20-page response limit. The Government may use the information received to refine the draft SOW and acquisition strategy; participation does not preclude responding to any future solicitation.
-Market Research11/25/2026
REQUEST FOR QUOTATION (RFQ) / COMBINED SYNOPSIS Solicitation Number: 75N98027Q00075 Notice Type: Combined Synopsis Posted Date: November 10, 2026 Response Date: November 25, 2026, 9:00 AM Eastern Standard Time Set-Aside: None NAICS Code: 811210 –Electronic and Precision Equipment Repair and Maintenance PSC Code: J066 GENERAL INFORMATION: This is a combined synopsis/solicitation for commercial products/services prepared in accordance with FAR Part 12. This announcement constitutes the only solicitation, and a separate written solicitation will not be issued. The National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development )NICHD), intends to contract on a sole source basis with Leica Microsystems Inc., 10 Parkway North, Suite 300, Deerfield, IL 60015 to procure a PremiumCare Service Plan for the following: PremiumCare The PremiumCare service plan includes the following: 1 annual preventative maintenance visit (PM) Unlimited on-site repairs, including replacement for service parts, components, or modules necessary for repairs (excluding lasers, unless quoted separately) Prioritized on-site response time for remedial services (critical repairs) Unlimited access to Leica OneCall Technical Support Center (standard working hours) 2-hour telephone call back from Leica OneCall Unlimited access to Remote Services (RemoteCare proactive monitoring) Firmware and software updates when available (excluding software upgrades and Windows upgrades) All services are performed by factory-trained and certified Field Service Engineers with genuine Leica Microsystems parts to meet Leica original equipment manufacturer (OEM) specifications. PremiumCare price is per unit per year. Please note the following options are also available upon request to complement your service coverage: Hardware Upgrades, Software Licenses, Accessories, Trainings, Professional Services. Contract Period: 01/01/2027-12/31/2027 Agreement Period: 01/01/2027-12/31/2027 Period of Performance: This will be a Base Year Plus Four Option Period Firm Fixed Price procurement. Base Year: 01/01/2027 -12/31/2027 Option Period 1: 01/01/2028 – 12/31/2028 Option Period 2: 01/01/2029–12/31/2029 Option Period 3: 01/01/2030–12/31/ 2030 Option Period 4: 01/01/2031–12/31/2031 Cost for the Base and Option Period must be included in the quote/response. The Government intends to solicit from a single source pursuant to FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements. This notice of intent is not a request for competitive quotations. However, all quotations received by the closing response date will be considered by the Government. A determination by the Government not to compete with this proposed contract based upon responses to this notice is solely within the discretion of the Government. Any non-original equipment manufacturer (OEM) offerors to this solicitation must include enough information to establish the interested parties’ bona-fide capabilities of providing all products and service (s) needed. Responses must be accompanied by descriptive literature, warranties and/or other information that demonstrates that the offer meets all the foregoing requirements. JUSTIFICATION FOR THE PROPOSED SOLE-SOURCE ACQUISITION: Only Leica Microsystems has technical service representatives who receive comprehensive, ongoing factory training and regular technical updates, as well as direct access to original manufacturer’s parts to maintain Leica Microsystems instruments in optimal condition. Only Leica Microsystems technical service representatives can engage directly with the engineering teams that designed the instruments to resolve advanced diagnostic and technical support needs Leica Microsystems is the sole source for this requirement because utilizing unauthorized third-party technicians to service the proprietary Leica Stellaris system to image chromosomes or sub-chromosomal regions in various tissue types, cell cycle stages will immediately void existing Leica Microsystems maintenance agreements, compromise critical optical calibrations, and result in costly out-of-pocket recertification fees. Considering the high cost (~$1.5 million) and high usage of the equipment, we would like to ensure the longevity of the Stellaris system by obtaining all services for the PremiumCare performed by factory-trained and certified Field Service Engineers with genuine Leica Microsystems parts that meets original equipment manufacturer (OEM) specifications. Furthermore, the required Protect Premium agreement provides features that a third-party administrator or broker cannot legally or technically deliver. DELIVERY / PLACE OF PERFORMANCE: National Institutes of Health 9000 Rockville Pike Bethesda, MD 20892 SUBMISSION INSTRUCTIONS: Quotations shall be submitted electronically to: Verne.Griffin@nih.gov Quotations are due no later than: November 25, 2026, prior to 9:00am Eastern Standard Time. Late submissions may be rejected and not considered for award. Response to the solicitation and any questions must be sent via email to verne.griffin@nih.gov and must include solicitation# 75N98027Q00075 in the subject line of email. PRE-AWARD PROVISION: 52.212-1 Instructions to Offerors- Instructions to Offerors—Commercial Products and Commercial Services. APPLICABLE FAR CLAUSES: 52.203-17 - Contractor Employee Whistleblower Rights 52.204-9 - Personal Identity Verification of Contractor Personnel 52.204-13 - System for Award Management Maintenance 52.209-6 - Protecting the Government's Interest When Subcontracting with Contractors Debarred, Suspended, or Proposed for Debarment 52.209-10 - Prohibition on Contracting with Inverted Domestic Corporations 52.212-4 - Terms and Conditions-Commercial Products and Commercial Services 52.217-9 - Option to Extend the Term of the Contract 52.222-3 - Convict Labor 52.222-19 - Child Labor-Cooperation with Authorities and Remedies 52.222-36 - Equal Opportunity for Workers with Disabilities 52.222-50 - Combating Trafficking in Persons 52.222-90 - Addressing DEI Discrimination by Federal Contractors 52.223-23 - Sustainable Products and Services 52.226-8 - Encouraging Contractor Policies to Ban Text Messaging While Driving 52.232-33 - Payment by Electronic Funds Transfer-System for Award Management 52.232-40 - Providing Accelerated Payments to Small Business Subcontractors 52.233-3 - Protest After Award 52.233-4 - Applicable Law for Breach of Contract Claim 52.240-91 - Security Prohibitions and Exclusions 52.244-6 - Subcontracts for Commercial Products and Commercial Services Note: System updates may lag policy updates. The System for Award Management (SAM) may continue to require entities to complete representations based on provisions that are not included in agency solicitations, including 52.223-22, Public Disclosure of Greenhouse Gas Emissions and Reduction Goals—Representation. Agencies will not consider or use these representations. Entities are not required to, nor are they able to, update their entity registration to remove these representations in SAM This award incorporates only the Government provided provisions and clauses and terms and conditions as stated in the award. Contractor provided terms and conditions, or agreement are for reference only. Should the terms of the Governments award document and the terms of the Contractor provided terms and conditions or agreement conflict, the Government provided provisions and clauses and terms and conditions shall control.
-Combined Synopsis11/25/2026
Please see attached Combined Synopsis/Solicitation. See attached estimated quantities and Questions and Answers.
-Combined Synopsis11/18/2026
(i)This is a combined synopsis/solicitation for commercial items prepared in accordancewith FAR Subpart 12.6, as supplemented with additional information included in thisnotice. This announcement constitutes the only solicitation; proposals are beingrequested, and a separate written solicitation will not be issued. (ii)The solicitation number is 75N98027Q00077. This solicitation is issued as a competitiveRequest for Quotation (RFQ) / combined synopsis/solicitation for commercial productsand commercial services using a Brand Name restriction in accordance with FAR 13.106-1(b)(1)(i). A Brand Name Justification is attached to this notice in accordance with FAR5.102(a)(6). This acquisition is conducted under the authority of FAR 12.603, StreamlinedSolicitation for Commercial Products or Commercial Services, in conjunction with FAR Part13 Simplified Acquisition Procedures, and is not expected to exceed the simplifiedacquisition threshold. The National Institutes of Health (NIH), Office of the Director, Officeof Acquisitions, seeks to award a Firm-Fixed-Price (FFP) Purchase Order to theresponsible offeror whose quotation represents the best value to the Government. (iii)The solicitation document and incorporated provisions and clauses are those in effectthrough Federal Acquisition Circular (FAC) number 2026-01 and effective date 03/13/2026. (iv)The associated NAICS code is 334516 (Analytical Laboratory InstrumentManufacturing), and the small business size standard is 1,000 employees. The ProductService Code (PSC) is 6640 (Laboratory Equipment and Supplies). [X]This requirement is set aside for Small Business concerns.
-Combined Synopsis11/24/2026

Additional Details

Solicitation Number

A75N98026R00138

Archive Date

Oct 17, 2026

Office Address

BETHESDA, MD, 20892